RAB27A and neoplasm: Reduced expression of Rab27a resulted in decreased sEV production, and in decreased release of pro-angiogenic factors (PlGF-2, osteopontin, and PDGF-AA) from tumor cells, interfering with BMDC mobilization and tumor invasiveness [74].